Преглед према Пројекат
mAbxience Research
Приказ резултата 1 до 3 од 3
| Година | Наслов | Аутор(и) | Тип резултата | Мп-кат. |
| 2021 | Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis. | Trukhin, Dmytro; Poddubskaya, Elena; Andric, Zoran G   ; Bondarenko, Igor N; Shevnia, Serhii; Zaric, Bojan ; Bellala, Ravishankar; Charoentum, Chaiyut; Perez, Luis; Bullo, Felicitas;
Garcia, Fernanda;
| Конференцијски рад | |
| 2020 | Bevacizumab biosimilar and reference bevacizumab in subjects with stage IIIB/IV no squamous non-small cell lung cancer (NSCLC) (STELLA study): Results for the primary endpoint in a confirmatory, double-blind, randomized, controlled study. | Millan, Susana; Trukhin, Dmytro; Kolesnik, Oleksii; Poddubskaya, Elena; Andric, Zoran G ; Bondarenko, Igor N; Shevnia, Serhii; Bullo, Felicitas; Sarnago, Cristina | Конференцијски рад | |
| 2021 | Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA) | Trukhin, Dmytro; ...; Andric, Zoran G ; ...; (broj, koautora 19) | Научни чланак | 21aM21a - Водећи међународни часопис категорије M21a |